Artwork

Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

14:00
 
Share
 

Manage episode 248298673 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field. For more information, please visit https://www.TriConference.com/Gene-Therapy
  continue reading

255 episodes

Artwork
iconShare
 
Manage episode 248298673 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field. For more information, please visit https://www.TriConference.com/Gene-Therapy
  continue reading

255 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide